For the fourth time now, the “Guide to German Medtech Companies” will be published this year.
Marijuana is the most widely trafficked illegal drug worldwide. But the list of European countries that see the clear medical benefits of the plant and want to legalise cannabis for medical purposes has grown long. Is this the beginning of a gold rush in the industry? The cover story of the recently published winter edition of European Biotechnology focuses on this issue.
What’s the latest in hemophilia therapeutics? Why could nanobots be the future of medicine? These are just two of the topics covered in the freshly printed issue of European Biotechnology.
Almost a quarter of a century ago, |transkript was launched as a news magazine: Readers found everything that was important in biotechnology in the DACH region on the pages of the magazine. Today, the daily news has moved to our website transkript.de. The time has come to redesign the journal. With the 2018 winter edition, |transkript will focus on in-depth information rather than news: professionally researched and written reports, reportages, discussions and comments.
Why do many investors rely on approaches with CAR-T cells? Why could the ECJ decision on genome editing pose a real threat to organic farming? These are two of the topics readers will find in the newly printed autumn issue of European Biotechnology.